| Product | Indication | Area | Non clinical | Phase I | Phase II | Phase III | NDA |
|---|---|---|---|---|---|---|---|
| OBP-301 | HCC |
|
|||||
| OBP-301 | Esophageal Cancer |
|
|||||
| OBP-301 | Gastric Cancer |
|
|||||
| OBP-301 | Head and Neck Cancer |
|
|||||
| Autologous Magicell®-NK | Colon Cancer |
|
|||||
| Allogeneic Magicell®-NK | PDA or CCA |
|